← Back to Search

Behavioural Intervention

Mobile Neurofeedback for Chronic Pain

N/A
Waitlist Available
Led By Eric B Elbogen, PhD
Research Sponsored by CrossComm, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Prescribed opioids for pain management
Reports chronic pain (≥4 on 0-10 Numeric Rating Scale (NRS) on most days during the past 3 months)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 3 month follow-up (end of intervention)
Awards & highlights

Study Summary

This trial will test a new mobile app that uses neurofeedback to help manage chronic pain.

Who is the study for?
This trial is for individuals who experience chronic pain (rated ≥4 on a scale of 0-10) most days over the past three months and are prescribed opioids. It's not suitable for those with a history of seizures, planned pain-related surgery within three months, or implanted devices that could be affected by EEG.Check my eligibility
What is being tested?
The study is testing a mobile neurofeedback app used in conjunction with an EEG headset. Participants will use this setup for 10 minutes at a time, four times weekly over twelve weeks to see if it helps reduce opioid use in chronic pain management.See study design
What are the potential side effects?
Since this trial involves non-invasive neurofeedback through an app and EEG headset, side effects may be minimal but can include discomfort from wearing the headset or potential stress from engaging with the neurofeedback process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am taking opioids for pain management.
Select...
I have experienced chronic pain most days in the last 3 months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 3 month follow-up (end of intervention)
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 3 month follow-up (end of intervention) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mobile App Usage
Secondary outcome measures
Mobile App Satisfaction assessed on a 5-point Likert scale (1: very dissatisfied - 5: very satisfied)
Mobile App Usability assessed by the System Usability Scale

Trial Design

1Treatment groups
Experimental Treatment
Group I: Mobile NeurofeedbackExperimental Treatment1 Intervention
Participants engage in the use of a mobile neurofeedback intervention, which involves using a mobile app paired with an EEG headset, to achieve a calm, relaxed state. Participants will be instructed to use the intervention at a minimum of 10 minutes a day, 4 times a week for a total of 12 weeks.

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH
2,468 Previous Clinical Trials
2,619,325 Total Patients Enrolled
55 Trials studying Chronic Pain
82,937 Patients Enrolled for Chronic Pain
CrossComm, Inc.Lead Sponsor
Duke UniversityOTHER
2,360 Previous Clinical Trials
3,420,307 Total Patients Enrolled
22 Trials studying Chronic Pain
11,110 Patients Enrolled for Chronic Pain

Media Library

Mobile Neurofeedback App (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04838925 — N/A
Chronic Pain Research Study Groups: Mobile Neurofeedback
Chronic Pain Clinical Trial 2023: Mobile Neurofeedback App Highlights & Side Effects. Trial Name: NCT04838925 — N/A
Mobile Neurofeedback App (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04838925 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are currently being monitored as part of this experiment?

"Affirmative. According to the information provided on clinicaltrials.gov, this medical experiment initiated recruitment efforts on June 22nd 2022 and last modified its details on July 18th 2022. The research is targeting 30 participants across a single centre."

Answered by AI

Are there any opportunities to join this experimental research at present?

"As evidenced on clinicaltrials.gov, this medical experiment is still signup participants; the trial was made available to the public on June 22nd 2022 and had its most recent update July 18th of the same year."

Answered by AI

Who else is applying?

What state do they live in?
Kentucky
North Carolina
How old are they?
65+
18 - 65
What site did they apply to?
Duke University School of Medicine Department of Psychiatry
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
0
Recent research and studies
clinicaltrials.govStudy
Using Mobile Devices for Neurofeedback to Reduce Opioid Use in Chronic Pain
2022. "Using Mobile Devices for Neurofeedback to Reduce Opioid Use in Chronic Pain". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04838925.
~8 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top